Discover the Extraordinary: Preferred Hotels & Resorts Presents Annual Live Like a Legend Experiences for 2025 The World's Largest Independent Hotel Brand Unveils Six Dream-worthy and Inspiring Luxury Travel Experiences, Offering Unforgettable, Rare Access to the Truly Exceptional GlobeNewswire October 21, 2025 NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) — Setting a new benchmark for […]

Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved GlobeNewswire October 21, 2025 Minerva secures $80 million up front and up

Restaurants could create 25,000 additional youth jobs with boost from permanent GST exemption GlobeNewswire October 21, 2025 Toronto, Oct. 21, 2025 (GLOBE NEWSWIRE) — The federal government could add more than 25,000 youth jobs in the foodservice industry by eliminating the GST from restaurant meals, according to analysis by Restaurants Canada. The foodservice industry already

Retail Investor Advocate Eric Jackson to join ProCap Financial Board of Directors GlobeNewswire October 21, 2025 â— ProCap BTC takes a bold step toward aligning corporate governance with the interests of everyday investors New York, NY, Oct. 21, 2025 (GLOBE NEWSWIRE) — Retail investors have increasingly become a driving force in the financial markets. While

Simcha Therapeutics Presents Preclinical Data Demonstrating Potential for Decoy-Resistant IL-18 to Enhance Efficacy of Bi-specific T-cell Engagers Findings presented at European Society for Medical Oncology include models in solid tumors and hematologic malignancies GlobeNewswire October 21, 2025 SOUTH SAN FRANCISCO, Calif., and NEW HAVEN, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — Simcha Therapeutics (“Simcha”), a

New TransUnion Research Reveals Marketers' Confidence in Measurement Has Stalled AI Adoption and long-term ROI strategies on the rise as most marketers face internal skepticism GlobeNewswire October 21, 2025 CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) — Marketers' confidence in measurement has plateaued at a time when it should be rising, according to new research from

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against LifeMD, Inc. (LFMD), Semler Scientific, Inc. (SMLR) and Quantum Corp. (QMCO) GlobeNewswire October 21, 2025 ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead plaintiff

Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook GlobeNewswire October 21, 2025 BENTONVILLE, Ark., Oct. 21, 2025 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC) today announced the appointment of Mark Schaftlein as Chief Executive Officer and member of the Board of Directors, effective October 20, 2025. The Company also announced

Holzer & Holzer, LLC Reminds Investors of Upcoming Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Tronox Holdings plc (TROX), Fly-E Group, Inc. (FLYE), and Savara Inc. (SVRA) GlobeNewswire October 21, 2025 ATLANTA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC reminds investors of the deadline to seek to be appointed lead

Mineralys Therapeutics Announces Late-Breaking Presentation of Phase 2 Explore-CKD Trial of Lorundrostat at American Society of Nephrology (ASN) Kidney Week 2025 GlobeNewswire October 21, 2025 ~ Late-breaking Phase 2 trial data evaluating the safety and efficacy of 25 mg of lorundrostat in participants with hypertension and comorbid CKD to be presented~ ~ Phase 3 data